| |
| Trade Name | Amplatzer Post-infarct Muscular VSD Occluder |
| Classification Name | transcatheter septal occluder |
| Generic Name | transcatheter septal occluder |
| Applicant |
| ABBOTT MEDICAL |
| 177 county rd. b e. |
| st. paul, MN 55117 |
|
| HDE Number | H070005 |
| Supplement Number | S018 |
| Date Received | 01/07/2021 |
| Decision Date | 02/07/2021 |
| Product Code | |
| Advisory Committee |
Cardiovascular |
| Supplement Type | normal 75 day track |
| Supplement Reason | postapproval study protocol |
| Expedited Review Granted? | No |
| Combination Product | No |
Approval Order Statement Which requested updates to the study protocol on informed consent for deceased patients for the post-approval study (pas) referenced above. The pas protocol has been submitted to comply with the conditions of approval outlined in our approval order for h070005, approved on january 11th, 2017. |